Combination antiretroviral therapy failure and HIV super-infection

被引:12
作者
Bezemer, Daniela [1 ]
van Sighem, Ard [1 ]
de Wolf, Frank [1 ,2 ]
Cornelissen, Marion [3 ]
van der Kuyl, Antoinette C. [3 ]
Jurriaans, Suzanne [3 ]
van der Hoek, Lia [3 ]
Prins, Maria [4 ,5 ]
Coutinho, Roe A. [5 ,6 ]
Lukashov, Vladimir V. [3 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, HIV Monitoring Fdn, NL-1105 AZ Amsterdam, Netherlands
[2] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,CINIMA, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[5] Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands
[6] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands
关键词
D O I
10.1097/QAD.0b013e3282f37489
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
In addition to development or selection of resistance, failure to continuously suppress HIV-1 production while still using initially effective combination antiretroviral therapy (cART) may result from super-infection with a drug-resistant strain. Both transmission of drug resistant HIV and super-infection have been demonstrated. We analysed HIV pol genes obtained before start of initially successful cART and during failure while still on cART in 101 patients. Difference in precART and cART failure sequences were explained by evolution and not by super-infection.
引用
收藏
页码:309 / 311
页数:3
相关论文
共 22 条
[1]
HIV-1 superinfection [J].
Allen, TM ;
Altfeld, M .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (05) :829-835
[2]
Declining trend in transmission of drug-resistant HIV-1 in Amsterdam [J].
Bezemer, D ;
Jurriaans, S ;
Prins, M ;
van der Hoek, L ;
Prins, JM ;
de Wolf, F ;
Berkhout, B ;
Coutinho, R ;
Back, NKT .
AIDS, 2004, 18 (11) :1571-1577
[3]
Persistence of mutidrug-resistant HIV-1 in primary infection leading to superinfection [J].
Brenner, B ;
Routy, J ;
Quan, YD ;
Moisi, D ;
Oliveira, M ;
Turner, D ;
Wainberg, MA ;
Baril, JG ;
Bélanger, M ;
Côté, P ;
Dufresne, S ;
Leplante, F ;
Lebel, J ;
Boissonnault, M ;
Lavoie, H ;
Lessard, B ;
Olivier, C ;
Trottier, RB ;
Vézina, S ;
Gilmore, N ;
Klein, M ;
Lalonde, P ;
MacLeod, J ;
Smith, G ;
Cholette, P ;
Laponte, N ;
Samson, J ;
Frenette, C ;
Valois, C ;
Bélanger, M .
AIDS, 2004, 18 (12) :1653-1660
[4]
Routine HIV-1 genotyping as a tool to identify dual infections [J].
Cornelissen, Marion ;
Jurriaans, Suzanne ;
Kozaczynska, Karolina ;
Prins, Jan M. ;
Hamidjaja, Raditijo A. ;
Zorgdrager, Fokla ;
Bakker, Margreet ;
Back, Nicole ;
van der Kuyl, Antoinette C. .
AIDS, 2007, 21 (07) :807-811
[5]
HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada [J].
Cox, J ;
Beauchemin, J ;
Allard, R .
SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 (06) :518-523
[6]
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus [J].
de Ronde, A ;
van Dooren, M ;
van der Hoek, L ;
Bouwhuis, D ;
de Rooij, E ;
van Gemen, B ;
de Boer, R ;
Goudsmit, J .
JOURNAL OF VIROLOGY, 2001, 75 (02) :595-602
[7]
HIV-1 superinfection is not a common event [J].
Diaz, RS ;
Pardini, R ;
Catroxo, M ;
Operskalski, EA ;
Mosley, JW ;
Busch, MP .
JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (04) :328-330
[8]
Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy [J].
Elford, J .
CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (01) :26-32
[9]
HIV-1 superinfections: omens for vaccine efficacy? [J].
Fultz, PN .
AIDS, 2004, 18 (01) :115-119
[10]
Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation [J].
Gonzales, MJ ;
Delwart, E ;
Rhee, SY ;
Tsui, R ;
Zolopa, AR ;
Taylor, J ;
Shafer, RW .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (03) :397-405